Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences)
;
(12): 879-884, 2016.
Artigo
em Chinês
| WPRIM
| ID: wpr-814947
ABSTRACT
Endocannabinoids and cannabinoid receptors are expressed in various central pain modulation regions. They maintain in dynamic changes in the expression level and distribution under different pathological and physiological conditions. These changes possess advantage as well as disadvantage. Exogenous administration of endocannabinoids exerts analgesic effect in different pain models, which is mainly mediated by the cannabinoid CB1 and CB2 receptors. Inhibition of enzymes for degrading endocannabinoids in different pain models also shows analgesic effect due to the increased local levels of endocannabinoids.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Receptor CB1 de Canabinoide
/
Receptor CB2 de Canabinoide
/
Endocanabinoides
/
Neuralgia
Limite:
Humanos
Idioma:
Chinês
Revista:
Journal of Central South University(Medical Sciences)
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS